Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Intermittent Fasting 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Overweight 1Obesity 1Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Exercise 24Metformin 19Tirzepatide 9Resistance Training 8Nutrition Assessment 8Methods 8Diet Therapy 8Diet 8Counseling 7Surveys and Questionnaires 6semaglutide 5Liraglutide 5Exenatide 5Early Intervention, Educational 5Diet, Mediterranean 5Caloric Restriction 5Blood Specimen Collection 5Educational Status 4Bariatric Surgery 4Vitamin D 3Sugars 3Standard of Care 3Naltrexone 3Letrozole 3Docosahexaenoic Acids 3Dexamethasone 3Bupropion 3exemestane 2bupropion hydrochloride, naltrexone hydrochoride drug combination 2Yoga 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Obesity × Diet, Healthy × Clear all
NCT06824974 2025-08-08

TRE+HE

University of California, San Diego

Phase NA Recruiting
50 enrolled
GastrointestinalOther

Intermittent Fasting, Carcinoma, Hepatocellular, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡